Here's Why Hype Around Companies Working on Coronavirus Treatments Is OverblownThe Motley Fool • 02/29/20
Why Inovio Pharmaceuticals, Gilead Sciences, Moderna, and Novavax Are All Jumping TodayThe Motley Fool • 02/27/20
Novavax’ Preclinical NanoFlu Data Published in Vaccines; Details Structural Basis for Broadly Neutralizing ImmunityGlobeNewsWire • 02/25/20